Form 4: OptimizeRx CFO Sells Shares to Cover Tax Obligations

Edward Stelmakh, CFO/COO of OptimizeRx Corp, disposed of 2,156 shares of common stock on February 15, 2025, to cover tax withholding obligations.

Summary

• On February 15, 2025, Edward Stelmakh, the CFO/COO of OptimizeRx Corp, disposed of 2,156 shares of common stock.
• The transaction was executed at a price of $6.64 per share.
• The shares were withheld by the issuer to satisfy the reporting person's tax withholding obligations.
• Following the transaction, Stelmakh beneficially owns 95,139 shares of OptimizeRx Corp.
• The reporting person has a power of attorney.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like the CFO/COO in this case, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects. However, in this case, the disposal was explicitly for tax obligations, which is a common and often neutral event.

Key Dates

Keywords

Form 4, OptimizeRx Corp, OPRX, Edward Stelmakh, CFO, COO, Share Disposal, Tax Withholding, Beneficial Ownership, Securities Exchange Act